SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 8.03 trillion as of April 28, 2026. Its market cap has increased by 2.91% in one year.

Market Cap

8.03T

Enterprise Value

7.79T

Revenue

706.74B

Ranking

n/a

PE Ratio

30.10

Stock Price

101,300.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.03T, a decrease of -19.21%. That is a compound annual growth rate of -3.60%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	8,034.94B	-17.66%
Dec 30, 2025	9,757.83B	12.15%
Dec 30, 2024	8,700.60B	10.66%
Dec 28, 2023	7,862.65B	39.25%
Dec 29, 2022	5,646.39B	-25.82%
Dec 30, 2021	7,612.05B	-42.49%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HLB Co., Ltd.	7,998.96B
LigaChem Biosciences	7,287.91B
Peptron	6,493.88B
Voronoi	5,516.62B
Samsung Epis Holdings	14.28T
OliX Pharmaceuticals	3,700.80B
D&D Pharmatech	3,583.18B
SK bioscience	3,475.63B

Market Cap Rankings